Mekan R. Orazov , Marina V. Kiseleva , Vladlena M. Pernay
Abstract
Over the past decades, there have been great advances in the understanding of serous borderline tumors of the ovary. Although most serous borderline tumors have a favorable outcome, recurrence and progression to carcinoma are possible. Serous borderline tumor of the ovaries is the most common among all borderline tumors. They are an intermediate group between benign and malignant formations. Most often, serous borderline tumors have a favorable outcome, but there are also cases of relapse and progression to malignancy. In this review, we will try to clarify what a serous borderline tumor is.
Key words: serous borderline ovarian tumor, classification, diagnosis, survival
About the Author
Mekan R. Orazov 1 , Marina V. Kiseleva 2 , Vladlena M. Pernay 11 Patrice Lumumba Peoples' Friendship University of Russia, Moscow, Russia;
2 National Medical Research Center of Radiology, Obninsk, Russia
References
2. Каприн А.Д. Старинский В.В., Шахзадова А.О. Состояние онкологической помощи населению России в 2021 г. 2022.
3. Киселева М.В. Денисов М.С., Литвякова Е.В., Иванов С.А. и др. Сохранение фертильности у больных раком молочной железы: Обзор литературы. Клинический разбор. 2023.
4. Киселева М.В. Малинова И.В., Комарова Е.В. и др. Cохранение фертильности у онкологических пациентов репродуктивного возраста методом витрификации овариальной ткани. Research'n Practical Med J 2016.
5. Beiner ME, Gotlieb WH, Davidson B, Kopolovic J. et al. Infertility treatment after conservative management of borderline ovarian tumor. Cancer 2001.
6. Bourdel N, Huchon C, Abdel Wahab C, Azaïs H. et al. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation. J Gynecol Obstet Hum Reprod 2021.
7. Boyraz G, Salman MC, Gultekin M, Ozkan NT et al. What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter case-control study. Arch Gynecol Obstet 2017.
8. Candotti G, Peiretti M, Mangili G, Bergamini A et al. What women want: fertility sparing surgery in borderline ovarian tumours patients and pregnancy outcome. Eur J Surg Oncol 2020.
9. Chen RF, Li J, Zhu TT, Yu HL et al. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience. J Ovarian Res 2016.
10. Crane EK, Thaker PH. Borderline tumors of the ovary. Wiley Blackwel 2017.
11. Gershenson DM Clinical management potential tumours of low malignancy. Best Pract. Res. Clin Obstetr Gynaecol 2002.
12. Du Bois A, Trillsch F, Mahner S, Heitz F, Harter P. Management of borderline ovarian tumors. Ann Oncol 2016.
13. Kurman RJ Carcangiu ML Herrington CS Young RHE. WHO classification of tumours of female reproductive organs. Lyon, France International Agency for Research on Cancer 2014.
14. Geoffron S, Lier A, de Kermadec E, Sermondade N et al. Fertility preservation in women with malignant and borderline ovarian tumors: experience of the French ESGO-certified center and pregnancy-associated cancer network (CALG). Gynecol Oncol 2021.
15. Falcone F, Malzoni M, Carnelli M Cormio G et al. Fertility-sparing treatment for serous borderline ovarian tumors with extra-ovarian invasive implants: analysis from the MITO14 study database. Gynecol Oncol 2022.
16. Fauvet R, Brzakowski M, Morice P, Resch B et al. Borderline ovarian tumors diagnosed during pregnancy exhibit a high incidence of aggressive features: results of a French multicenter study. Ann Oncol 2012.
17. Filippi F, Martinelli F, Somigliana E, Franchi D et al. Oocyte cryopreservation in two women with borderline ovarian tumor recurrence. J Assist Reprod Genet 2020.
18. Fortin A, Morice P, Thoury A, Camatte S et al. mpact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study. Fertil Steril 2007.
19. Давыдова И.Ю. Карселадзе А.И., Кузнецов В.В., Ашрафян Л.А. и др. Практические рекомендации по лечению пограничных опухолей яичников. Злокачественные опухоли. 2021.
20. Gaurilcikas A, Gedgaudaite M, Cizauskas A, Atstupenaite V et al. Performance of the IOTA ADNEX Model on Selected Group of Patients with Borderline Ovarian Tumours Medicina (Kaunas) 2020.
21. Gotlieb WH, Chetrit A, Menczer J, Hirsh-Yechezkel G et al. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol 2005.
22. Guadagno E, Pignatiello S, Borrelli G et al. Ovarian borderline tumors, a subtype of neoplasm with controversial behavior. Role of Ki67 as a prognostic factor. Pathol Res Pract 2019.
23. Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderlin tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria Virchows Arch 2017.
24. Sahin H, Akdogan AI, Smith J et al Serous borderline ovarian tumours: an extensive review on MR imaging features. Brit J Radiol 2021.
25. Ikeda Y, Yoshihara M, Yoshikawa N, Tamauchi S et al. Is cystectomy an option as conservative surgery for young patients with borderline ovarian tumor? A multi-institutional retrospective study. Int J Gynaecol Obstet 2022.
26. Jia SZ, Xiang Y, Yang JJ, Shi JH et al. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study. Hum Reprod 2020.
27. Johansen G, Dahm-Kähler P, Staf C, Flöter Rådestad A et al. Reproductive and obstetrical outcomes with the overall survival of fertile-age women treated with fertility-sparing surgery for borderline ovarian tumors in Sweden: a prospective nationwide population-based study. Fertil Steril 2021.
28. Khiat S, Provansal M, Bottin P, et al. Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours. Eur J Obstet Gynecol Reprod Biol 2020.
29. Koskas M, Uzan C, Gouy S, Pautier P et al. Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma). Hum Reprod 2011.
30. Koutlaki N, Dimitraki M, Zervoudis S, Sofiadou V et al. Conservative surgery for borderline ovarian tumors — emphasis on fertility preservation: A review. Chirurgia (Bucur.) 2011.
31. Kuji S, Harada M, Yoshioka N, Kajiyama H et al. urvival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: results of a retrospective nationwide study. J Obstet Gynaecol Res 2022.
32. Kumari S, Kumar S, Bhatla N, Mathur S et al. Oncologic and reproductive outcomes of borderline ovarian tumors in Indian population. Gynecol Oncol Rep 2021.
33. Kurman R, Carcangiu M L, Herrington CS, Young RH eds. WHO classification of tumours of female reproductive organs 4th ed.Lyon. IARC Press 2014; Т. 9.
34. Lertkhachonsuk AA, Buranawongtrakoon S, Lekskul N, Rermluk N et al Serum CA19-9, CA-125 and CEA as tumor markers for mucinous ovarian tumors. J Obstet Gynaecol Res 2020.
35. Li S, Lin H, Xie Y, Jiao X et al. Live births after in vitro fertilization with fertility-sparing surgery for borderline ovarian tumors: a case series and literature review. Gynecol Obstet Invest 2019.
36. Mangili G, Somigliana E, Giorgione V, Martinelli F et al. Fertility preservation in women with borderline ovarian tumours. Cancer Treat Rev 2016.
37. Maramai M, Barra F, Menada MV et al. Borderline ovarian tumours: management in the era of fertility-sparing surgery. Ecancermedicalscience 2020.
38. Nagamine M, Mikami Y. Ovarian seromucinous tumors: pathogenesis, morphologic spectrum, and clinical issues: Diagnostics (Basel) 2020.
39. Nayyar N. Lakhwani P., Goel A. et al. Management of borderline ovarian tumors — still a gray zone Indian. J Surg Oncol 2017.
40. Otify M, Laios A, Elshamy T, D'Angelo A, Amso NN A systematic review and meta-analysis of the use of ultrasound to diagnose borderline ovarian tumours. Eur J Obstet Gynecol Reprod Biol 2020.
41. Palomba S, Zupi E, Russo T, Falbo A. et al. Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study. Hum Reprod 2007.
42. Plett H, Harter P, Ataseven B et al. Fertility-sparing surgery and reproductive — outcomes in patients with borderline ovarian tumors. Gynecol Oncol 2020.
43. Poncelet C, Fauvet R, Boccara J, Daraï E Reccurence after cystectomy for borderline ovarian tumors: results of a French multicenter study. Ann Surg Oncol 2006.
44. Poncelet C, Fauvet R, Boccara J, Daraï E. Reccurence after cystectomy for borderline ovarian tumors: results of a French multicenter study. Ann Surg Oncol 2006.
45. Rasmussen CB, Kjaer SK, Albieri V et al. Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies. Am J Epidemiol 2017.
46. Rasmussen ELK, Hannibal CG, Dehlendorff C, et al. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study. Gynecol Oncol 2017.
47. RH. Young Ovarian tumors: a survey of selected advances of note during the life of this journal. Hum Pathol 2020.
48. Sun H, Chen X, Zhu T, Liu N et al. Age-dependent difference in impact of fertility preserving surgery on disease-specific survival in women with stage I borderline ovarian tumors. J Ovarian Res 2018.
49. Sun Y, Xu J, Jia X. he Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderline Ovarian Tumors Current Status and Perspectives Cancer Manag Res 2020.
50. Sun Y, Xu J, Jia X. The diagnosis, treatment, prognosis and molecular pathology of borderline ovarian tumors: current status and perspectives Cancer Manag Res 2020.
51. Tal O, Ganer H H, Gluck O et al. Characteristics and prognosis of borderline ovarian tumors in pre and postmenopausal patients. Arch Gynecol Obstet 2020.
52. van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM et al. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort Hum. Reprod 2011.
53. Yasmeen S, Hannan A, Sheikh F, Syed AA, Siddiqui N. Borderline tumors of the ovary: A clinicopathological study. Pak J Med Sci 2017.
54. Zuo T, Wong S, Buza N, Hui P. KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome. Mod Pathol 2018.
55. Ожиганова И.Н. Морфология рака яичников в классификации ВОЗ 2013 года. Практическая онкол. 2014.
56. Новикова Е.Г. Шевчук А.С., Завалишина Л.Э. Некоторые аспекты органосохраняющего лечения пограничных опухолей яичников. Рос. онкол. журн. 2010.
For citation:Orazov M.R., Kiseleva M.V., Pernay V.M. Methods to preserve fertility in patients with serous borderline ovarian tumors. Clinical analysis in general medicine. 2024; 5 (3): 82–87. (In Russ.). DOI: 10.47407/kr2023.5.3.00376
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
